CompoAtlas

Wess Cream

Natural health product licensed in Canada

Other names
Bambella Cream
Licence holder
Pioneer Globe Corp.
NPN or DIN-HM
80142821
Status
Active licence
Licence date
22 July 2025
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
(2,5-dioxo-4-imidazolidinyl)urée

Source : Allantoïne

0.2 %
Oxyde de zinc

Source : Oxyde de zinc

4 %

Non-medicinal ingredients

Extrait d'Aloe barbadensis, Huile de fleurs de Chamomilla recutita (Matricaire camomille), Panthénol, Extrait de Thymus serpyllum (Thym sauvage), Paraffine liquide légère, NA, Triéthanolamine, Alcool cétylique, Huile de pépins de raisin, Monostéarate de glycéryle, Acide stéarique, Glycérine, Eau purifiée, Silicium, Extrait de feuilles de Glycyrrhiza glabra (Réglisse), Huile de jojoba

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 1 year ; maximum: 12 yearsNot specifiedNot specified
Nourrissonsmaximum: 12 monthsNot specifiedNot specified
Adolescentesminimum: 13 years ; maximum: 17 yearsNot specifiedNot specified
AdultesNot specifiedNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps prevent diaper rash. Helps protect from wetness that causes diaper rash. Helps treat/heal diaper rash. Protects chafed skin/minor skin irritation due to diaper rash. Temporarily helps relieve minor skin irritation due to diaper rash.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80142821

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line